Mineralys Therapeutics Inc (MLYS)

02:06 AM

Earnings Miss: Whats the RSI of Mineralys Therapeutics Inc stock2026 Levels & Capital Protection Trading Alerts - baoquankhu1.vn

02:06 AM

Apr 02, 2026

Mineralys Therapeutics CEO Congleton sells $1.97 million in MLYS stock By Investing.com - Investing.com Australia

Apr 02, 2026

Apr 02, 2026

Insider Sell: CEO Jon Congleton Sells 75,000 Shares of Mineralys Therapeutics Inc (MLYS) - GuruFocus

Apr 02, 2026

Apr 02, 2026

Mineralys Therapeutics (NASDAQ:MLYS) CEO Jon Congleton Sells 75,000 Shares - MarketBeat

Apr 02, 2026

Apr 02, 2026

Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Director Sells 3,000 Shares of Stock - MarketBeat

Apr 02, 2026

Apr 02, 2026

Daphne Karydas, director at Mineralys, sells $75,000 in MLYS stock By Investing.com - Investing.com Australia

Apr 02, 2026

Apr 02, 2026

Daphne Karydas, director at Mineralys, sells $75,000 in MLYS stock - Investing.com

Apr 02, 2026

Apr 02, 2026

Mineralys Therapeutics CEO Congleton sells $1.97 million in MLYS stock - Investing.com

Apr 02, 2026

Apr 02, 2026

Mineralys (MLYS) CEO sells 75,000 shares, still holds 705k - Stock Titan

Apr 02, 2026

Apr 02, 2026

Mineralys Therapeutics (MLYS) director trades 3,000 shares under plan - Stock Titan

Apr 02, 2026

Apr 02, 2026

IPO Launch: How sensitive is Mineralys Therapeutics Inc to inflationMarket Rally & AI Enhanced Market Trend Forecasts - baoquankhu1.vn

Apr 02, 2026

Apr 02, 2026

Mineralys Therapeutics (NASDAQ:MLYS) Director Acquires $7,354,269.00 in Stock - MarketBeat

Apr 02, 2026

Apr 02, 2026

Mineralys Therapeutics, Inc. (MLYS) stock price, news, quote and history - Yahoo Finance UK

Apr 02, 2026

Apr 01, 2026

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) and Gain Therapeutics (GANX) - The Globe and Mail

Apr 01, 2026

Apr 01, 2026

Mineralys Therapeutics Surges on FDA Milestone Buzz - TipRanks

Apr 01, 2026

Apr 01, 2026

Mineralys Therapeutics (MLYS) Garnering Attention With Lorundrostat Progress - Insider Monkey

Apr 01, 2026

Apr 01, 2026

Mineralys Therapeutics(MLYS.US) Director Buys US$8.76 Million in Common Stock - 富途牛牛

Apr 01, 2026

Mar 31, 2026

Mineralys Therapeutics (NASDAQ: MLYS) insider sells 3,000 shares - Stock Titan

Mar 31, 2026

Mar 31, 2026

Mineralys Therapeutics (MLYS) files Form 144 to sell 75,000 shares - Stock Titan

Mar 31, 2026

Mar 31, 2026

RA Capital funds add 369,000 Mineralys (NASDAQ: MLYS) shares - Stock Titan

Mar 31, 2026

Mar 31, 2026

Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Up 12.4%What's Next? - MarketBeat

Mar 31, 2026

Mar 31, 2026

Investors Purchase High Volume of Mineralys Therapeutics Put Options (NASDAQ:MLYS) - MarketBeat

Mar 31, 2026

Mar 31, 2026

Immunic appoints biopharmaceutical executive Jon Congleton to board - Yahoo! Finance Canada

Mar 31, 2026

Mar 31, 2026

Ex-Copaxone launch executive joins Immunic board as MS trial nears - stocktitan.net

Mar 31, 2026

Mar 31, 2026

(MLYS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Mar 31, 2026

Mar 31, 2026

SG Americas Securities LLC Buys 130,758 Shares of Mineralys Therapeutics, Inc. $MLYS - MarketBeat

Mar 31, 2026

Mar 31, 2026

Major Insider Power Move Signals Growing Confidence in Mineralys Therapeutics - TipRanks

Mar 31, 2026

Mar 27, 2026

Mineralys Therapeutics, Inc.Common Stock (NQ: MLYS - FinancialContent

Mar 27, 2026

Mar 26, 2026

Mineralys reports 2025 results, advances hypertension drug review - MSN

Mar 26, 2026

Mar 25, 2026

Mineralys Therapeutics names Jeffrey Munsie as chief legal officer By Investing.com - Investing.com Australia

Mar 25, 2026

Mar 24, 2026

Biopharma Co. Gives New CLO $3.6 Million In Stock Awards - Law360

Mar 24, 2026

Mar 24, 2026

Mineralys Therapeutics grants inducement equity awards to two new employees - msn.com

Mar 24, 2026

Mar 24, 2026

Mineralys Therapeutics appoints Jeffrey Munsie as chief legal officer - TipRanks

Mar 24, 2026

Mar 24, 2026

Mineralys Grants Inducement Equity Awards to New Employee - MyChesCo

Mar 24, 2026

Mar 24, 2026

Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer - citybiz

Mar 24, 2026

Mar 24, 2026

Mineralys Therapeutics names Jeffrey Munsie as chief legal officer - Investing.com

Mar 24, 2026

Mar 24, 2026

Mineralys Therapeutics appoints Jeffrey A. Munsie as chief legal officer - MarketScreener

Mar 24, 2026

Mar 24, 2026

Mineralys Therapeutics Appoints Jeffrey A. Munsie As Chief Legal Officer - TradingView

Mar 24, 2026

Mar 23, 2026

Mineralys Therapeutics (MLYS) Is Down 8.1% After Narrowed Loss, FDA Lorundrostat NDA AcceptanceWhat's Changed - simplywall.st

Mar 23, 2026

Mar 22, 2026

Hudson Bay Capital Management LP Invests $2.87 Million in Mineralys Therapeutics, Inc. $MLYS - MarketBeat

Mar 22, 2026

Mar 22, 2026

Earnings Beat: Whats the profit margin of Mineralys Therapeutics IncQuarterly Risk Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn

Mar 22, 2026

Mar 21, 2026

Growth Value: What is the implied volatility of Mineralys Therapeutics Inc2026 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

Is It Time To Reassess Mineralys Therapeutics (MLYS) After The Recent Share Price Pullback? - Yahoo Finance

Mar 20, 2026

Mar 19, 2026

Mineralys (MLYS) Q4 2025 Earnings Call Transcript - AOL.com

Mar 19, 2026

Mar 18, 2026

Why Mineralys Therapeutics Shares Are Sliding Today - TipRanks

Mar 18, 2026

Mar 18, 2026

Research Analysts Issue Forecasts for MLYS Q1 Earnings - MarketBeat

Mar 18, 2026

Mar 17, 2026

Rodman David Malcom sells Mineralys Therapeutics (MLYS) stock for $10,696 - Investing.com Canada

Mar 17, 2026

Mar 17, 2026

Insider sale notices at Mineralys Therapeutics (NASDAQ: MLYS) detail multiple Q1 2026 transactions - Stock Titan

Mar 17, 2026